WO2025238615 - COMBINATIONS OF HETEROCYCLIC DNA-PK INHIBITORS AND ANTIBODY-DRUG CONJUGATES (ADC) FOR USE IN THE TREATMENT OF CANCER
National phase entry is expected:
Publication Number
WO/2025/238615
Publication Date
20.11.2025
International Application No.
PCT/IB2025/055140
International Filing Date
16.05.2025
Title **
[English]
COMBINATIONS OF HETEROCYCLIC DNA-PK INHIBITORS AND ANTIBODY-DRUG CONJUGATES (ADC) FOR USE IN THE TREATMENT OF CANCER
[French]
COMBINAISONS D'INHIBITEURS D'ADN-PK HÉTÉROCYCLIQUES ET DE CONJUGUÉS ANTICORPS-MÉDICAMENT (ADC) DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DU CANCER
Applicants **
KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD.
Inventors
WEI, Yonggang
YE, Fei
SUN, Yi
Priority Data
202410610535.4
16.05.2024
CN
202411380616.6
30.09.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3152 | |
| EPO | Filing, Examination, Granting | 24232 | |
| Japan | Filing, Examination, Granting | 3120 | |
| South Korea | Filing, Examination, Granting | 3851 | |
| USA | Filing, Examination, Granting | 9740 |
Total:
44,095
Contact Us
Abstract[English]
Provided herein is the use of a DNA-PK inhibitor in combination with an ADC for the treatment of a tumor.[French]
L'invention concerne l'utilisation d'un inhibiteur d'ADN-PK en association avec un ADC pour le traitement d'une tumeur.